Laromustine
- Generic Name
- Laromustine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C6H14ClN3O5S2
- CAS Number
- 173424-77-6
- Unique Ingredient Identifier
- 14J2G0U3NQ
- Background
VNP40101M is a novel alkylating agent that has been used in trials studying the treatment of Leukemia, Lymphoma, Lung Cancer, Small Intestine Cancer, and Myelodysplastic Syndromes, among others.
- Indication
Investigated for use/treatment in brain cancer, cancer/tumors (unspecified), colorectal cancer, leukemia (lymphoid), leukemia (myeloid), lung cancer, myelodysplastic syndrome, pediatric indications, and solid tumors.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath